» Articles » PMID: 11387246

Induction and Suppression of Interferon-inducible Protein 10 in Reperfused Myocardial Infarcts May Regulate Angiogenesis

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2001 Jun 2
PMID 11387246
Citations 47
Authors
Affiliations
Soon will be listed here.
Citing Articles

Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.

Hilgendorf I, Frantz S, Frangogiannis N Circ Res. 2024; 134(12):1718-1751.

PMID: 38843294 PMC: 11164543. DOI: 10.1161/CIRCRESAHA.124.323658.


Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus.

Ullah A, Zhao J, Singla R, Shen B Front Cell Dev Biol. 2023; 11:1272536.

PMID: 37928902 PMC: 10620730. DOI: 10.3389/fcell.2023.1272536.


Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction.

Sopova K, Tual-Chalot S, Mueller-Hennessen M, Vlachogiannis N, Georgiopoulos G, Biener M Front Immunol. 2023; 14:1177467.

PMID: 37426649 PMC: 10326041. DOI: 10.3389/fimmu.2023.1177467.


Transforming growth factor-β in myocardial disease.

Frangogiannis N Nat Rev Cardiol. 2022; 19(7):435-455.

PMID: 34983937 DOI: 10.1038/s41569-021-00646-w.


Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Julian D, Kazakoff M, Patel A, Jaynes J, Willis M, Yates C Curr Pathobiol Rep. 2021; 9(4):93-105.

PMID: 34900402 PMC: 8651461. DOI: 10.1007/s40139-021-00226-0.